69 related articles for article (PubMed ID: 20944645)
1. Identification of exonic cis-elements regulating the alternative splicing of scleroderma-associated lysyl hydroxylase 2 mRNA.
Seth P; Walker LC; Yeowell HN
J Invest Dermatol; 2011 Feb; 131(2):537-9. PubMed ID: 20944645
[No Abstract] [Full Text] [Related]
2. Fox-2 protein regulates the alternative splicing of scleroderma-associated lysyl hydroxylase 2 messenger RNA.
Seth P; Yeowell HN
Arthritis Rheum; 2010 Apr; 62(4):1167-75. PubMed ID: 20131247
[TBL] [Abstract][Full Text] [Related]
3. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
4. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers.
Ramalho AS; Beck S; Penque D; Gonska T; Seydewitz HH; Mall M; Amaral MD
J Med Genet; 2003 Jul; 40(7):e88. PubMed ID: 12843337
[No Abstract] [Full Text] [Related]
5. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?
Brinckmann J; Kim S; Wu J; Reinhardt DP; Batmunkh C; Metzen E; Notbohm H; Bank RA; Krieg T; Hunzelmann N
Matrix Biol; 2005 Oct; 24(7):459-68. PubMed ID: 16139999
[TBL] [Abstract][Full Text] [Related]
6. A null-mutated lysyl hydroxylase gene in a compound heterozygote British patient with Ehlers-Danlos syndrome type VI.
Heikkinen J; Pousi B; Pope M; Myllylä R
Hum Mutat; 1999 Oct; 14(4):351. PubMed ID: 10502784
[TBL] [Abstract][Full Text] [Related]
7. A compound heterozygote patient with Ehlers-Danlos syndrome type VI has a deletion in one allele and a splicing defect in the other allele of the lysyl hydroxylase gene.
Pousi B; Hautala T; Hyland JC; Schröter J; Eckes B; Kivirikko KI; Myllylä R
Hum Mutat; 1998; 11(1):55-61. PubMed ID: 9450904
[TBL] [Abstract][Full Text] [Related]
8. A missense mutation in the APC tumor suppressor gene disrupts an ASF/SF2 splicing enhancer motif and causes pathogenic skipping of exon 14.
Gonçalves V; Theisen P; Antunes O; Medeira A; Ramos JS; Jordan P; Isidro G
Mutat Res; 2009 Mar; 662(1-2):33-6. PubMed ID: 19111562
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the lysyl hydroxylase 1 gene that result in enzyme deficiency and the clinical phenotype of Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC
Mol Genet Metab; 2000; 71(1-2):212-24. PubMed ID: 11001813
[TBL] [Abstract][Full Text] [Related]
10. Identification of a cis-acting element involved in the regulation of BACE1 mRNA alternative splicing.
Mowrer KR; Wolfe MS
J Neurochem; 2009 May; 109(4):1008-16. PubMed ID: 19302194
[TBL] [Abstract][Full Text] [Related]
11. TIA nuclear proteins regulate the alternate splicing of lysyl hydroxylase 2.
Yeowell HN; Walker LC; Mauger DM; Seth P; Garcia-Blanco MA
J Invest Dermatol; 2009 Jun; 129(6):1402-11. PubMed ID: 19110540
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation (c.951C>T) in an exonic splicing enhancer results in exon 10 skipping in the human mitochondrial acetoacetyl-CoA thiolase gene.
Fukao T; Horikawa R; Naiki Y; Tanaka T; Takayanagi M; Yamaguchi S; Kondo N
Mol Genet Metab; 2010 Aug; 100(4):339-44. PubMed ID: 20488739
[TBL] [Abstract][Full Text] [Related]
13. GnRH pre-mRNA splicing: role of exonic splicing enhancer.
Han J; Son GH; Seong JY; Kim K
Prog Brain Res; 2002; 141():209-19. PubMed ID: 12508572
[No Abstract] [Full Text] [Related]
14. An exonic splicing enhancer within a bidirectional coding sequence regulates alternative splicing of an antisense mRNA.
Salato VK; Rediske NW; Zhang C; Hastings ML; Munroe SH
RNA Biol; 2010; 7(2):179-90. PubMed ID: 20200494
[TBL] [Abstract][Full Text] [Related]
15. A large duplication in the gene for lysyl hydroxylase accounts for the type VI variant of Ehlers-Danlos syndrome in two siblings.
Hautala T; Heikkinen J; Kivirikko KI; Myllylä R
Genomics; 1993 Feb; 15(2):399-404. PubMed ID: 8449506
[TBL] [Abstract][Full Text] [Related]
16. Complete genomic structure of mouse lysyl hydroxylase 2 and lysyl hydroxylase 3/collagen glucosyltransferase.
Ruotsalainen H; Vanhatupa S; Tampio M; Sipilä L; Valtavaara M; Myllylä R
Matrix Biol; 2001 Apr; 20(2):137-46. PubMed ID: 11334715
[TBL] [Abstract][Full Text] [Related]
17. Splicing of phenylalanine hydroxylase (PAH) exon 11 is vulnerable: molecular pathology of mutations in PAH exon 11.
Heintz C; Dobrowolski SF; Andersen HS; Demirkol M; Blau N; Andresen BS
Mol Genet Metab; 2012 Aug; 106(4):403-11. PubMed ID: 22698810
[TBL] [Abstract][Full Text] [Related]
18. An exonic splicing enhancer mutation in
Cao C; Zhang Y; Jia Q; Wang X; Zheng Q; Zhang H; Song R; Li Y; Luo A; Hong Q; Qin G; Yao J; Zhang N; Wang Y; Wang H; Zhou Q; Zhao J
Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30651277
[TBL] [Abstract][Full Text] [Related]
19. A common duplication in the lysyl hydroxylase gene of patients with Ehlers Danlos syndrome type VI results in preferential stimulation of lysyl hydroxylase activity and mRNA by hydralazine.
Yeowell HN; Walker LC; Murad S; Pinnell SR
Arch Biochem Biophys; 1997 Nov; 347(1):126-31. PubMed ID: 9344473
[TBL] [Abstract][Full Text] [Related]
20. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis.
van der Slot AJ; Zuurmond AM; Bardoel AF; Wijmenga C; Pruijs HE; Sillence DO; Brinckmann J; Abraham DJ; Black CM; Verzijl N; DeGroot J; Hanemaaijer R; TeKoppele JM; Huizinga TW; Bank RA
J Biol Chem; 2003 Oct; 278(42):40967-72. PubMed ID: 12881513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
